MedPath

Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia

Not Applicable
Conditions
Residual Aphasia
Interventions
Device: atDCS
Device: sham tDCS
Registration Number
NCT01845129
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The present study assesses whether language functions in patients with residual post-stroke aphasia can be improved by transcranial direct current stimulation administered to the primary motor cortex in the language dominant (left) hemisphere.

Detailed Description

Patients will participate in two tDCS sessions (atDCS; sham) in a cross-over within subjects design. tDCS or placebo will be administered during simulatneous fMRI to assess neural signatures of the stimulation. Order of stimulation will be counterbalanced between subjects

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
16
Inclusion Criteria
  • right handedness
  • German native speaker
  • cerebrovascular stroke in left hemisphere (>6 months)
  • mild aphasia (according to Aachen Aphasia Test Battery Classification, Huber et al., 1983)
  • residual anomia in naming test (>75 correct responses)
Exclusion Criteria
  • other current or previous neurological or psychiatric diseases
  • alcohol or drug abuse
  • MRI contraindication (e.g. magnetic metal, pacemaker, claustrophobia)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
anodal tDCSatDCSatDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex
anodal tDCSsham tDCSatDCS will be administered for 20 minutes with 1 milliampere (1 mA) to the left primary hand motor cortex
sham tDCSatDCSsham tDCS will be administered to the left primary hand motor cortex
sham tDCSsham tDCSsham tDCS will be administered to the left primary hand motor cortex
Primary Outcome Measures
NameTimeMethod
Response latency during picture naming task (max. 80)Change in response latency between assessment 1 (week 1) and assessment 2 (week 2), assessments 1 and 2 are seperated by one week

Subjects are assessed in a cross-over design. The primary outcome measure will be assessed twice in each subject, either during placebo ("sham) stimulation or active (anodal) stimulation with transcranial direct current stimulation. Order of stimulation will be counterbalanced across the group.

Secondary Outcome Measures
NameTimeMethod
Change in neural activity measured by functional magnetic resonance imagingChange in fMRI activity between Assessment 1 (week 1) and Assessment 2 (week 2), assessments 1 and 2 are seperated by one week

Trial Locations

Locations (1)

Charite, University Medicine, Dept. of Neurology

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath